At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 51 enrolled
Drug / intervention
Fluzone® 2009-2010 Formula +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 1, 2009
In Brief
A Phase 4 clinical trial evaluating Fluzone® 2009-2010 Formula and FluMist® 2009-2010 Formula for Influenza. Completed, enrolled 51 participants across 1 site.
Detailed Summary
This is an exploratory study using a strategy that has not been previously employed to investigate the effects of age and vaccine type on specific kinds of immune responses to licensed, seasonal 2009-2010 influenza vaccines in children and adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
Primary CompletionDec 2009
First PostedMay 2014
TodayJul 2026
First PostedMay 8, 2014
Enrollment StartJul 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.2 years ago
Interventions
Fluzone® 2009-2010 Formulabiological
This vaccine is given intramuscularly
FluMist® 2009-2010 Formulabiological
This vaccine is given intranasally